Active TBS-DLPFC
Active TBS-DLPFC is a medical device with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation
Personalized Therapeutic Neuromodulation for Anhedonic Depression
Rapid Acting Transcranial Magnetic Stimulation
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty
Clinical Trials (6)
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation
Personalized Therapeutic Neuromodulation for Anhedonic Depression
Rapid Acting Transcranial Magnetic Stimulation
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6